Esra Arslan

450 total citations
65 papers, 281 citations indexed

About

Esra Arslan is a scholar working on Oncology, Cancer Research and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Esra Arslan has authored 65 papers receiving a total of 281 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 21 papers in Cancer Research and 20 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Esra Arslan's work include Peptidase Inhibition and Analysis (15 papers), Medical Imaging Techniques and Applications (11 papers) and Protease and Inhibitor Mechanisms (10 papers). Esra Arslan is often cited by papers focused on Peptidase Inhibition and Analysis (15 papers), Medical Imaging Techniques and Applications (11 papers) and Protease and Inhibitor Mechanisms (10 papers). Esra Arslan collaborates with scholars based in Türkiye, Antigua and Barbuda and Cambodia. Esra Arslan's co-authors include Tevfik Fikret Çermik, Nurhan Ergül, Esra Canan Kelten Talu, Nevra Dursun, Metin Halaç, Özgül Ekmekçioğlu, Ahmet Kocael, Kerim Sönmezoğlu, Cihan Gündoğan and Özgür Yiğit and has published in prestigious journals such as SHILAP Revista de lepidopterología, BMC Musculoskeletal Disorders and Seminars in Nuclear Medicine.

In The Last Decade

Esra Arslan

49 papers receiving 273 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Esra Arslan Türkiye 9 133 119 115 55 52 65 281
Antonella Fontana Italy 8 71 0.5× 47 0.4× 68 0.6× 54 1.0× 148 2.8× 26 293
Emine Göknur Işık Türkiye 10 169 1.3× 71 0.6× 128 1.1× 66 1.2× 118 2.3× 41 313
Riena P. Aliredjo Netherlands 6 49 0.4× 43 0.4× 92 0.8× 52 0.9× 114 2.2× 9 272
Hongyu Zhou China 11 90 0.7× 37 0.3× 82 0.7× 56 1.0× 61 1.2× 32 402
Veronica Cox United States 10 102 0.8× 52 0.4× 37 0.3× 134 2.4× 89 1.7× 23 357
Minh Thi Tieu Australia 10 86 0.6× 118 1.0× 118 1.0× 61 1.1× 50 1.0× 16 345
Lu Wen China 12 105 0.8× 39 0.3× 141 1.2× 43 0.8× 37 0.7× 27 329
E. Van Limbergen Belgium 8 98 0.7× 95 0.8× 145 1.3× 73 1.3× 98 1.9× 26 372
Olivia Kertels Germany 8 84 0.6× 28 0.2× 83 0.7× 37 0.7× 30 0.6× 24 217

Countries citing papers authored by Esra Arslan

Since Specialization
Citations

This map shows the geographic impact of Esra Arslan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esra Arslan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esra Arslan more than expected).

Fields of papers citing papers by Esra Arslan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esra Arslan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esra Arslan. The network helps show where Esra Arslan may publish in the future.

Co-authorship network of co-authors of Esra Arslan

This figure shows the co-authorship network connecting the top 25 collaborators of Esra Arslan. A scholar is included among the top collaborators of Esra Arslan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esra Arslan. Esra Arslan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arslan, Esra, et al.. (2025). Prognostic and Predictive Values of F-18 FDG PET/CT Volumetric Parameters in Small Cell Lung Cancer. DergiPark (Istanbul University). 4(3). 1–12.
2.
Arslan, Esra, et al.. (2024). Predictors of recurrence in breast cancer patients with pathological partial response. Revista da Associação Médica Brasileira. 70(3). e20231215–e20231215.
3.
4.
Arslan, Esra, et al.. (2022). Diffuse Large B-Cell Non-Hodgkin Lymphoma Involving Multiple Different Organs in a Young Adult with <sup>18</sup>F-FDG PET/CT. Molecular Imaging and Radionuclide Therapy. 31(1). 72–74. 1 indexed citations
5.
6.
Arslan, Esra, et al.. (2022). Investigation of the Presence of Integrin Alpha-3 and Beta-1 Receptors on Tumor Tissue, Metastatic Lymph Node and Normal Tissue in Thyroid Cancer. Molecular Imaging and Radionuclide Therapy. 31(2). 75–81. 1 indexed citations
7.
Gündoğan, Cihan, et al.. (2022). Prognostic Significance of <sup>18</sup>F-FDG PET/CT Imaging in Survival Outcomes in Patients with Renal Cell Carcinoma. Molecular Imaging and Radionuclide Therapy. 31(3). 200–206.
8.
Arslan, Esra, et al.. (2022). Late-Term Findings of Pancreatitis on 68Ga-PSMA PET/CT in a Patient With Prostate Cancer. Clinical Nuclear Medicine. 47(12). e733–e734.
9.
10.
Arslan, Esra, et al.. (2021). Factors affecting pathological complete response after neoadjuvant chemotherapy in breast cancer: a single-center experience. Revista da Associação Médica Brasileira. 67(6). 845–850. 3 indexed citations
11.
Arslan, Esra, et al.. (2021). Malignant Otitis Externa: How to Monitor the Disease in Outcome Estimation?. Medeniyet Medical Journal. 36(1). 23–29. 9 indexed citations
12.
Arslan, Esra, et al.. (2020). Alternative volumetric PET parameters for evaluation of breast cancer cases with 18F‐FDG PET/CT imaging: Metabolic tumour volume and total lesion glycolysis. Journal of Medical Imaging and Radiation Oncology. 65(1). 38–45. 4 indexed citations
13.
Dursun, Nevra, et al.. (2020). Prognostic Value of Preoperative Neutrophil-lymphocyte/ Platelet-lymphocyte Ratio in Patients with Stage II-III Rectal Cancer Who Underwent Curative Resection. SHILAP Revista de lepidopterología. 21(5). 384–390. 2 indexed citations
14.
Arslan, Esra, et al.. (2020). Comparison of serum NEDD-9, CA 15-3, and CEA levels and PET metabolic parameters in breast cancer patients with 18 F-FDG PET / CT. Revista da Associação Médica Brasileira. 66(5). 673–679. 2 indexed citations
15.
Arslan, Esra, et al.. (2020). Metabolic Characteristics and Diagnostic Contribution of 18F-FDG PET/CT in Gastric Carcinomas. Molecular Imaging and Radionuclide Therapy. 29(1). 25–32. 8 indexed citations
16.
Arslan, Esra, et al.. (2020). The Prognostic Value of <sup>18</sup>F-FDG PET/CT and KRAS Mutation in Colorectal Cancers. Molecular Imaging and Radionuclide Therapy. 29(1). 17–24. 14 indexed citations
17.
Yaman, Mehmet, et al.. (2019). The Evaluation of the Effect of Cranioplasty on Cerebral Metabolism Using F-18 FDG PET/CT. SHILAP Revista de lepidopterología. 20(3). 193–197. 1 indexed citations
18.
Bayrak, Savaş, Ceyda Turan Bektaş, Aytül Hande Yardımcı, et al.. (2016). Preoperative localization of distal colorectal tumours.. PubMed. 87. 595–600. 3 indexed citations
19.
Arslan, Esra, Andreas Bayer, Andreas Prescher, et al.. (2016). Effect of platelet mediator concentrate (PMC) on Achilles tenocytes: an in vitro study. BMC Musculoskeletal Disorders. 17(1). 307–307. 6 indexed citations
20.
Arslan, Esra, Aytül Çorbacıoğlu Esmer, Serdar Aydın, et al.. (2012). Prediction of metabolic syndrome in women with polycystic ovary syndrome. Journal of the Turkish-German Gynecological Association. 13(3). 178–183. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonella Fontana Breakdown of academic impact, for papers by Emine Göknur Işık Breakdown of academic impact, for papers by Riena P. Aliredjo Breakdown of academic impact, for papers by Hongyu Zhou Breakdown of academic impact, for papers by Veronica Cox Breakdown of academic impact, for papers by Minh Thi Tieu Breakdown of academic impact, for papers by Lu Wen Breakdown of academic impact, for papers by E. Van Limbergen Breakdown of academic impact, for papers by Olivia Kertels
Rankless by CCL
2026